Sandra Lesenfants, senior vice president of Abbott’s Structural Heart business, shares an update on MitraClip, TriClip, and ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Among valves with taller frames, the Portico/Navitor (Abbott) and Acurate Neo/Neo2 (Boston Scientific) devices both resulted in better access to the coronary arteries when compared with the Evolut Pro ...

Meanwhile, the Navitor valve developers have come out with the ... and grant support from Abbott, JenaValve, and W.L. Gore & Associates. Yadav reported receiving personal fees from Edwards ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

The trial studied the use of Edwards Lifesciences’ (EW) TAVR valve in patients with asymptomatic aortic stenosis ... but this data should also help Medtronic (MDT) and Abbott (ABT), to a lesser extent ...

Valve actuators mount on valves and, in response to a signal, move a valve to a desired position using an outside power source. Selecting the correct valve actuator will increase uptime, reduce ...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products ...

Brianna Abbott is a health reporter covering the treatment and prevention of disease, with a special focus on cancer, in The Wall Street Journal’s Health and Science bureau. She writes stories ...

Oct 16 (Reuters) - Abbott Laboratories (ABT.N), opens new tab slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for quarterly earnings on strong demand ...

Abbott Laboratories will announce its Q3 results on the morning of 16th October, with earnings and topline growth largely expected to be in line with the Q2 trend. A year ago, all of Abbott's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...